Is routine multivitamin supplementation necessary in US chronic adult hemodialysis patients? A systematic review

Journal of Renal Nutrition

Volumn 25, Issue 3, 2015, Pages 257-264

  Tucker, Bryan M ^a   Safadi, Sami ^b   Friedman, Allon N ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN;

ADULT; ADVERSE EFFECTS; AVITAMINOSIS; DIET SUPPLEMENTATION; DRUG COST; ECONOMICS; HUMAN; NUTRITIONAL REQUIREMENT; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; UNITED STATES;

ADULT; AVITAMINOSIS; DIETARY SUPPLEMENTS; DRUG COSTS; HUMANS; NUTRITIONAL REQUIREMENTS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; VITAMINS;

EID: 84928208542     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.09.003     Document Type: Review

References (86)

1. Murray R., Granner D., Mayes P., Rodwell V. Harper's Illustrated Biochemistry 2003, Lange Medical Books/McGraw-Hill, New York, NY.
2. Makoff R. Vitamin replacement therapy in renal failure patients. Miner Electrolyte Metab 1999, 25:349-351.
3. Steiber A.L., Kopple J.D. Vitamin status and needs for people with stages 3-5 chronic kidney disease. J Ren Nutr 2011, 21:355-368.
4. Waxman S., Corcino J.J., Herbert V. Drugs, toxins and dietary amino acids affecting vitamin B12 or folic acid absorption or utilization. Am J Med 1970, 48:599-608.
5. Andreucci V.E., Fissell R.B., Bragg-Gresham J.L., et al. Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis 2004, 44(5 suppl 2):61-67.
6. DaVita vitamin recommendations. 2014. Accessed August 12,2014. http://www.davita.com/kidney-disease/diet-and-nutrition/diet-basics/the-abcs-of-vitamins-for-kidney-patients/e/5311.
7. Fresenius vitamin recommendations. 2013. Accessed August 12,2014. http://www.ultracare-dialysis.com/HealthyLifestyles/EatHealthy/Vitamins%20and%20Nutrients.aspx.
8. National Kidney and Urologic Diseases Information Clearinghouse. Accessed August 12,2014. http://kidney.niddk.nih.gov/kudiseases/pubs/hemodialysis/#dietm%20NKF%20website.
9. National Kidney Foundation. 2013. Accessed August 12,2014. http://www.kidney.org.
10. United States Renal Data System. 2013. Accessed August 12,2014. http://www.usrds.org/default.aspx.
11. Pricing of Dialyvite. 2010. Accessed September 11,2014. http://www.dialyvite.net/dialyvite-rx.html.
12. Pricing of nephrocaps. Accessed September 11,2014. http://www.goodrx.com/nephrocaps.
13. Xiao Q., Murphy R.A., Houston D.K., Harris T.B., Chow W.H., Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013, 173:639-646.
14. Lawson K.A., Wright M.E., Subar A., et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007, 99:754-764.
15. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996, 334:1150-1155.
16. Isanaka S., Mugusi F., Hawkins C., et al. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 2012, 308:1535-1544.
17. Dietary Reference Intakes for Calcium and Vitamin D 2011, Institute of Medicine of the National Academies, The National Academies Press, Washington, DC.
18. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005, 45(4 suppl 3):S1-S153. K/DOQI Workgroup.
19. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 2009, 53(3 suppl 2):S11-S104. Group KW.
20. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009, S1-S130. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease-Mineral and Bone Disorder Working Group.
21. Goldsmith D.J., Covic A., Fouque D., et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant 2010, 25:3823-3831.
22. Guidelines on Food and Fortification with Micronutrients 2006, World Health Organization Food and Agricultural Organization of the United Nations, http://www.who.int/nutrition/publications/guide_food_fortification_micronutrients.pdf. Accessed October 17, 2014.
23. Longo D.L. Harrison's Principles of Internal Medicine 2012, McGraw-Hill, New York, NY. 18th ed.
24. Hung S.C., Hung S.H., Tarng D.C., Yang W.C., Chen T.W., Huang T.P. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001, 38:941-947.
25. Ramirez G., Chen M., Boyce H.W., et al. The plasma and red cell vitamin B levels of chronic hemodialysis patients: a longitudinal study. Nephron 1986, 42:41-46.
26. Frank T., Bitsch R., Maiwald J., Stein G. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine. Eur J Clin Pharmacol 2000, 56:251-257.
27. Ihara M., Ito T., Yanagihara C., Nishimura Y. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 1999, 101:118-121.
28. Schupp N., Dette E.M., Schmid U., et al. Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:283-291.
29. Pietrzak I., Baczyk K. Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy. Miner Electrolyte Metab 1997, 23:277-282.
30. Berger M.M., Shenkin A., Revelly J.P., et al. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004, 80:410-416.
31. Thiamine fortification in Asia. Accessed August 12,2014. http://www.ffinetwork.org/regional_activity/asia.php.
32. Takahashi Y., Tanaka A., Nakamura T., et al. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 2004, 65:1099-1104.
33. Corken M., Porter J. Is vitamin B(6) deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology 2011, 16:619-625.
34. Kopple J.D., Mercurio K., Blumenkrantz M.J., et al. Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int 1981, 19:694-704.
35. Fortin M.C., Amyot S.L., Geadah D., Leblanc M. Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy. Intensive Care Med 1999, 25:594-598.
36. Kasama R., Koch T., Canals-Navas C., Pitone J.M. Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature. Am J Kidney Dis 1996, 27:680-686.
37. Heinz J., Domrose U., Westphal S., Luley C., Neumann K.H., Dierkes J. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology 2008, 13:384-389.
38. Friedman A.N., Bostom A.G., Laliberty P., Selhub J., Shemin D. The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study. Am J Kidney Dis 2003, 41:442-446.
39. Yango A., Shemin D., Hsu N., et al. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Kidney Int 2001, 59:324-327.
40. Oguma S., Ando I., Hirose T., et al. Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial. Tohoku J Exp Med 2012, 227:217-223.
41. Mason J.B., Dickstein A., Jacques P.F., et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007, 16:1325-1329.
42. Bostom A.G., Carpenter M.A., Kusek J.W., et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation 2011, 123:1763-1770.
43. Teschner M., Kosch M., Schaefer R.M. Folate metabolism in renal failure. Nephrol Dial Transplant 2002, 17(suppl 5):24-27.
44. Jamison R.L., Hartigan P., Kaufman J.S., et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007, 298:1163-1170. [Erratum appears in JAMA. 2008 Jul 9;300(2):170].
45. Wrone E.M., Hornberger J.M., Zehnder J.L., McCann L.M., Coplon N.S., Fortmann S.P. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004, 15:420-426.
46. Bostom A.G., Shemin D., Gohh R.Y., et al. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int Suppl 2001, 78:S246-S252.
47. Canavese C., Petrarulo M., Massarenti P., et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005, 45:540-549.
48. Wang S., Eide T.C., Sogn E.M., Berg K.J., Sund R.B. Plasma ascorbic acid in patients undergoing chronic haemodialysis. Eur J Clin Pharmacol 1999, 55:527-532.
49. Montazerifar F., Hashemi M., Karajibani M., Dikshit M. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans. J Med Food 2010, 13:1490-1493.
50. Maldonado I., Prasad V., Reginato A.J. Oxalate crystal deposition disease. Curr Rheumatol Rep 2002, 4:257-264.
51. Rock C.L., Jahnke M.G., Gorenflo D.W., Swartz R.D., Messana J.M. Racial group differences in plasma concentrations of antioxidant vitamins and carotenoids in hemodialysis patients. Am J Clin Nutr 1997, 65:844-850.
52. Zhang K., Dong J., Cheng X., et al. Association between vitamin C deficiency and dialysis modalities. Nephrology 2012, 17:452-457.
53. Candan F., Gultekin F., Candan F. Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients. Cell Biochem Funct 2002, 20:95-98.
54. Singer R.F. Vitamin C supplementation in kidney failure: effect on uraemic symptoms. Nephrol Dial Transplant 2011, 26:614-620.
55. MacGinley R., Westhuyzen J., Saltissi D., et al. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer. ASAIO J 2001, 47:66-73.
56. Zima T., Janebova M., Nemecek K., Bartova V. Retinol and alpha-tocopherol in hemodialysis patients. Ren Fail 1998, 20:505-512.
57. Libetta C., Zucchi M., Gori E., et al. Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int 2004, 65:1473-1481.
58. Kalousova M., Kubena A.A., Kostirova M., et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis 2010, 56:513-521.
59. Espe K.M., Raila J., Henze A., et al. Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 2011, 26:4054-4061.
60. Smith K.S., Lee C.L., Ridlington J.W., Leonard S.W., Devaraj S., Traber M.G. Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. Lipids 2003, 38:813-819.
61. Pastor M.C., Sierra C., Bonal J., Teixido J. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 1993, 13:238-243.
62. Ono K. Effects of large dose vitamin E supplementation on anemia in hemodialysis patients. Nephron 1985, 40:440-445.
63. Westenfeld R., Krueger T., Schlieper G., et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012, 59:186-195.
64. Reichel H. No effect of vitamin K1 supplementation on biochemical bone markers in haemodialysis patients. Nephrol Dial Transplant 1999, 14:249-250.
65. Fusaro M., Noale M., Viola V., et al. Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 2012, 27:2271-2278.
66. Schlieper G., Westenfeld R., Kruger T., et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011, 22:387-395.
67. Wolf M., Shah A., Gutierrez O., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007, 72:1004-1013.
68. Nigwekar S.U., Bhan I., Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 2012, 60:139-156.
69. Goodman W.G. When is vitamin D contraindicated in dialysis patients?. Semin Dial 2009, 22:245-247.
70. Khosla N., Sprague S.M. When is Vitamin D contraindicated in dialysis patients?. Semin Dial 2009, 22:249-251.
71. Macpherson H., Pipingas A., Pase M.P. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2013, 97:437-444.
72. Grodstein F., O'Brien J., Kang J.H., et al. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med 2013, 159:806-814.
73. Sun Y., Lu C.J., Chien K.L., Chen S.T., Chen R.C. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 2007, 29:2204-2214.
74. Pipingas A., Camfield D.A., Stough C., et al. The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment. Appetite 2013, 69:123-136.
75. Sesso H.D., Christen W.G., Bubes V., et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012, 308:1751-1760.
76. Graat J.M., Schouten E.G., Kok F.J. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002, 288:715-721.
77. Fissell R.B., Bragg-Gresham J.L., Gillespie B.W., et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004, 44:293-299.
78. Milunsky A., Jick H., Jick S.S., et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989, 262:2847-2852.
79. Saltzman E., Karl J.P. Nutrient deficiencies after gastric bypass surgery. Annu Rev Nutr 2013, 33:183-203.
80. Langan S.M., Farrell P.M. Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa. Am J Clin Nutr 1985, 41:1054-1060.
81. Allen L.H. Causes of vitamin B12 and folate deficiency. Food Nutr Bull 2008, 29(suppl 2):S20-S34. discussion S35-S37.
82. Duggan S.N., Smyth N.D., O'Sullivan M., Feehan S., Ridgway P.F., Conlon K.C. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract 2014, 29:348-354.
83. Prey S., Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol 2009, 160:622-628.
84. Snider D.E. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980, 61:191-196.
85. Nephrocap content. Accessed January 17,2014. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54753dd9-dd90-40ee-a50d-47a7fa5b4754.
86. Nephrovite content. Accessed August 12,2014. http://www.pdr.net/drug-summary/nephro-vite?druglabelid=2744.